Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia (Q36208652)

12 August 2017

Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia (English)

1 reference

12 August 2017

1 reference

Malachi Griffith

3

0 references

Christopher A. Miller

object named as

Christopher A Miller

2

0 references

Obi Griffith

object named as

Obi L Griffith

15

0 references

Catrina Fronick

21

object named as

Catrina Fronick

1 reference

12 August 2017

33

Elaine R Mardis

1 reference

12 August 2017

29

Timothy A Graubert

1 reference

12 August 2017

13

Jack Baty

1 reference

12 August 2017

17

Jasreet Hundal

1 reference

12 August 2017

7

Lukas D Wartman

1 reference

12 August 2017

12

Jacqueline E Payton

1 reference

12 August 2017

9

Tamara L Lamprecht

1 reference

12 August 2017

Jeffery M Klco

1

1 reference

12 August 2017

Allegra Petti

4

1 reference

12 August 2017

David H Spencer

5

1 reference

12 August 2017

Shamika Ketkar-Kulkarni

6

1 reference

12 August 2017

Matthew Christopher

8

1 reference

12 August 2017

Nicole M Helton

10

1 reference

12 August 2017

Eric J Duncavage

11

1 reference

12 August 2017

Sharon E Heath

14

1 reference

12 August 2017

Dong Shen

16

1 reference

12 August 2017

Gue Su Chang

18

1 reference

12 August 2017

Robert Fulton

19

1 reference

12 August 2017

Michelle O'Laughlin

20

1 reference

12 August 2017

Vincent Magrini

22

1 reference

12 August 2017

Ryan T Demeter

23

1 reference

12 August 2017

David E Larson

24

1 reference

12 August 2017

Shashikant Kulkarni

25

1 reference

12 August 2017

Bradley A Ozenberger

26

1 reference

12 August 2017

John S Welch

27

1 reference

12 August 2017

Matthew J Walter

28

1 reference

12 August 2017

Peter Westervelt

30

1 reference

12 August 2017

Jerald P Radich

31

1 reference

12 August 2017

Daniel C Link

32

1 reference

12 August 2017

John F DiPersio

34

1 reference

12 August 2017

Richard K Wilson

35

1 reference

12 August 2017

Timothy J Ley

36

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2015

1 reference

The Journal of the American Medical Association

12 August 2017

1 reference

12 August 2017

314

1 reference

12 August 2017

8

1 reference

12 August 2017

811-822

1 reference

Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Functional heterogeneity of genetically defined subclones in acute myeloid leukemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Minimal residual disease in acute myeloid leukaemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Minimal residual disease in acute myeloid leukemia: coming of age.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of allogeneic stem-cell transplantation

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

PLINK: a tool set for whole-genome association and population-based linkage analyses

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4621257

Abnormal Cytogenetics at Date of Morphologic Complete Remission Predicts Short Overall and Disease-Free Survival, and Higher Relapse Rate in Adult Acute Myeloid Leukemia: Results From Cancer and Leukemia Group B Study 8461

22 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26305651

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prognostic index for adult patients with acute myeloid leukemia in first relapse

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26305651

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Persistence ofDNMT3Amutations at long-term remission in adult patients with AML

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26305651

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1001/JAMA.2015.9643

1 reference

12 August 2017

1 reference

12 August 2017

1 reference